CONSULTING AGREEMENTConsulting Agreement • March 27th, 2020 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Consulting Agreement (herein referred to as “Agreement”) is made and entered into on January 2, 2019, effective as of January 1, 2019 (the “Effective Date”), by and between Monopar Therapeutics, Inc. (herein referred to as “Monopar”), a Delaware corporation, located at 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091, and pRx Consulting, LLC (herein referred to as pRx), a Delaware corporation located at # (each herein referred to as “Party” and collectively as “Parties”).
MONOPAR THERAPEUTICS INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • March 27th, 2020 • Monopar Therapeutics • Pharmaceutical preparations • Delaware
THIS INCENTIVE STOCK OPTION AGREEMENT (this “Agreement”) is made as of _____________ (the “Grant Date”) between MONOPAR THERAPEUTICS INC. (the “Company”) and ________________ (referred to herein as “Participant”). Terms used in this Agreement with initial capital letters without definitions are defined in the Monopar Therapeutics Inc. 2016 Stock Incentive Plan (the “Plan”) and have the same meaning in this Agreement.
MONOPAR THERAPEUTICS INC. NONQUALIFIED STOCK OPTION AGREEMENTNonqualified Stock Option Agreement • March 27th, 2020 • Monopar Therapeutics • Pharmaceutical preparations • Delaware
THIS NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”) is made as of _______________ (the “Grant Date”) between MONOPAR THERAPEUTICS INC. (the “Company”) and __________________ (referred to herein as “Participant”). Terms used in this Agreement with initial capital letters without definitions are defined in the Monopar Therapeutics Inc. 2016 Stock Incentive Plan (the “Plan”) and have the same meaning in this Agreement.
